MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

β-CGRP

MCE 國(guó)際站：β-CGRP (mouse)

品牌：MedChemExpress (MCE)

貨號(hào)：HY-P0203B

Synonyms：Calcitonin gene-related peptide 2 (mouse); CGRP II (mouse)

純度：99.77%

存儲(chǔ)條件：Sealed storage, away from moisture Powder -80°C 2 years -20°C 1 year *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

運(yùn)輸條件：美國(guó)大陸的室溫；其他地方可能有所不同。

產(chǎn)品活性：β-CGRP (mouse) 是一種能誘導(dǎo)血管舒張的降鈣素基因相關(guān)肽。β-CGRP (mouse) 可用于心血管、促炎、偏頭痛和代謝研究。

生物活性：β-CGRP（小鼠）是一種降鈣素基因相關(guān)肽，可誘導(dǎo)血管舒張。β-CGRP（小鼠）可用于心血管、促炎、偏頭痛和代謝研究[1]。

Sequence：Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Leu-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asp-Val-Gly-Ser-Glu-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys7)

熱銷(xiāo)產(chǎn)品：Bimekizumab  | WM-8014  | 5'-Methylthioadenosine  | Teriparatide  | Prexasertib  | p-SCN-Bn-DOTA  | Palivizumab  | Nicotinamide riboside (chloride)  | CCR2 antagonist 1  | PDK4-IN-1 (hydrochloride)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

參考文獻(xiàn)：

[1]. Whitby K, et al. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol. 2005 Jul;79(14):8698-706.
[2]. Xu H, et al. Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide α-CGRP Modulates Group 2 Innate Lymphoid Cell Responses. Immunity. 2019 Oct 15;51(4):696-708.e9.
[3]. Arulmani U, et al. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats. Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):291-7.
[4]. Park SH, et al. Role of α-CGRP in the regulation of neurotoxic responses induced by kainic acid in mice. Peptides. 2013 Jun;44:158-62.
[5]. McLatchie LM, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998 May 28;393(6683):333-9.